ArticleThoracic cancer2023

Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second-line chemotherapy in patients with small cell lung cancer.

Motoki Sekikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.